Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis - Maine Technology Institute

Sign up for our updates and announcements

June 16, 2022 |

Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

Read more here.

Categories:

© 2025 Maine Technology Institute. All rights reserved. Privacy

en_USEnglish
es_ESSpanish fr_FRFrench arArabic pt_PTPortuguese soSomali viVietnamese en_USEnglish